This Cooperative Agreement award of $998,527 from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of a temperature control and insulation system for storing and transporting temperature-sensitive materials such as medications, biologics, and other perishable components. The key innovation involves decoupling the thermoelectric coolers from the cooled payload to minimize energy use while maintaining precise...
This Cooperative Agreement award from the National Science Foundation's (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program provides $1,248,531 to Inaedis, Inc., a for-profit company based in Princeton, New Jersey, to develop a Rapid Room Temperature Aerosol Dehydration (RTAD) platform technology. The project aims to create a scalable system for continuous dehydration of temperature-sensitive biopharmaceutical formulations, including proteins, enzymes, viral vectors, and...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award of $274,918 to Cascade Biocatalysts Inc. will fund research and development to demonstrate the commercial feasibility and scalability of a patent-pending approach for stabilizing enzymes through engineered polymer-enzyme interactions. The goal is to enable environmentally sustainable, low-carbon chemical manufacturing processes that utilize enzymes as catalysts, which can decrease...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant award for $305,000 supports the development of a novel magnetocaloric cooling system for temperature-controlled transportation of sensitive goods. The project aims to create a reusable, refrigerant-free cooling solution that can reliably maintain temperatures between 5°C and -20°C, replacing energy-intensive and environmentally-harmful packaging like dry ice and expanded polystyrene. The...
This $996,291 Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of innovative products for extending the shelf life of perishable agricultural products. The recipient, RYP Labs, Inc., a self-certified small disadvantaged business, aims to create safe, natural bioactive formulations derived from plant-based essential oils to mitigate post-harvest food decay. The project focuses on...
The National Science Foundation (NSF) awarded a $273,706 Project Grant under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Matmerize, Inc., a for-profit organization, to develop a physics-informed/encoded polymer informatics platform to accelerate the development of advanced polymers and formulations. The project aims to transform the way polymeric materials are developed by adopting advanced artificial intelligence techniques to dramatically expedite the...
This National Science Foundation (NSF) Small Business Technology Transfer (STTR) Phase I grant, awarded under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program, provides $274,991 to Duravax Inc. to develop thermostable formulations of mRNA vaccines and therapeutics. The project aims to overcome the cold-chain limitations of current mRNA products by demonstrating the feasibility of storing mRNA APIs and mRNA-lipid nanoparticles at room temperature for extended periods. If...
This $2,996,108 Cooperative Agreement awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (CFDA 47.084) program supports the development of more efficient cell-free biomanufacturing processes. The project aims to introduce membrane-less coacervate droplets that encapsulate enzymes and artificial redox cofactors within spatially organized compartments, enabling efficient cofactor recycling and precise delivery of reducing and oxidizing power....
This Cooperative Agreement award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program provides $2,233,515 to Arzeda Corp to develop a biocatalytic process for producing bio-based acrylate monomers. The project aims to transform the production of acrylates, which are high-value chemicals used in paints, plastics, and absorbent materials, by leveraging artificial intelligence-driven protein engineering to create stable,...
This $3,091,750 Cooperative Agreement award from the National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) program will support the development of a modular, standardized platform for cell-free bioprocessing. The project aims to create eight reusable functional modules covering essential capabilities like energy generation and protein expression. These "ready-to-use" modules will enable faster, more efficient product development by allowing...